scispace - formally typeset
E

Eric Dale Jones

Researcher at Monash University, Parkville campus

Publications -  23
Citations -  390

Eric Dale Jones is an academic researcher from Monash University, Parkville campus. The author has contributed to research in topics: Prodrug & Integrase inhibitor. The author has an hindex of 11, co-authored 23 publications receiving 375 citations.

Papers
More filters
Journal ArticleDOI

Structural basis for a new mechanism of inhibition of HIV-1 integrase identified by fragment screening and structure-based design

TL;DR: A new site in integrase is defined as a valid region for the structure-based design of allosteric integrase inhibitors, which has improved the activity of the initial fragments 45-fold and is used to develop these fragments into more potent novel enzyme inhibitors.
Patent

Integrase inhibitors 3

TL;DR: In this article, a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof is presented.
Journal ArticleDOI

Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold

TL;DR: HIV integrase inhibitors based on a novel bicyclic pyrimidinone core is presented, leading to optimization of the 6:6 core giving compound 48 with an EC(50) of 3 nM against wild type HIV infected T-cells.
Journal ArticleDOI

Examination of the Role of Intestinal Fatty Acid-Binding Protein in Drug Absorption Using a Parallel Artificial Membrane Permeability Assay

TL;DR: It is suggested that intracellular lipid-binding proteins such as I-FABP may enhance the membrane transport of lipophilic xenobiotics and facilitate drug access to the enterocyte cytoplasm and cy toplasmic organelles.